Annals of Hematology

Article	Citations
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning	64
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration	62
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma	60
Clonal evolution analysis of a rare acute promyelocytic leukemia patient transforming from essential thrombocythemia	48
Germline mutations predispose a concurrent thymoma and diffuse large B-cell lymphoma	42
Optimizing hemophagocytic lymphohistiocytosis screening in children: validation of the HLH-Screen score	35
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome	35
Second allogeneic transplantation in relapsed acute leukemia – a risk worth taking?	34
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study	34
Prognostic significance of in patients with chronic lymphocytic leukemia: A meta-analysis	33
Radiotherapy alone with curative intent in a case of limited-stage extranodal NK/T-cell lymphoma nasal type: a case report and review of the literature	32
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients	32
Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data	29
Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation	27
Activity of trametinib as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory RAS pathway-mutated hematologic malignancies	25
Symposium Proceedings of the international symposium ACUTE LEUKEMIAS XIX (ISALXIX), Munich March 16–19, 2025	25
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis	24
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts	24
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants	24
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia	23
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders	22
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrosp	22
T-cell acute lymphoblastic leukemia: therapeutic outcomes in adolescents and young adults	21
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib	21
Ferroptosis: a new target for iron overload-induced hemophilic arthropathy synovitis	21

Correction to: Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea	21
Nomogram for predicting survival of patients with diffuse large B-cell lymphoma	20
A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia	20
Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma	20
“In situ” MYC rearrangement and amplification as a secondary change in a case of High-grade B cell lymphoma with 11q aberration	19
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia	19
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia	19
Incidence of pneumonia among bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis of clinical trials	19
Clinical profile and treatment outcomes in paediatric and adult acute promyelocytic leukemia: experience from a tertiary care centre in Northern India	19
Circulating tumor DNA assisting lymphoma genetic feature profiling and identification	18
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma	18
Paroxysmal nocturnal haemoglobinuria in pregnancy–a systematic review with meta analysis	18
Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis	18
Maternal factors associated with iron deficiency without anaemia in early pregnancy: ECLIPSES study	18
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia	18
Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trials	17
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multipl	17
Global, regional and national temporal trends in incidence and mortality of non-Hodgkin lymphoma from 1992 to 2021: an age-period-cohort analysis	17
Molecular profiling of cell-free DNA from classic Hodgkin lymphoma patients identifies potential prognostic clusters and corresponds with disease dynamics	17
Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015	17
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group	17
Basophilia and eosinophilia in polycythemia vera and essential thrombocythemia: clinical, genotype, and prognostic correlates	17
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study	16
Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome	16
Post-transplant lymphoproliferative disease of two different histological types	16
Efficacy and safety analysis of different treatment regimens in newly diagnosed acute promyelocytic leukemia	16
Molecular response with asciminib 20 mg QD in a patient intolerant to multiple TKIs	16
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension	16
Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade	16
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis	16
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study	16
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease	16
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive acute lymphoblastic leukemia	16
Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments	16
Advances in the ocular complications after hematopoietic stem cell transplantation	16
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience	16
Reporting of adverse events of treatment interventions in multiple myeloma: an overview of systematic reviews	16
Advances in epigenetic therapies for B-cell non-hodgkin lymphoma	15
Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p	15
Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture	15
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry	15
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Inf	14
Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies	14
The first successful expanded compassionate use of Iptacopan in a patient with paroxysmal nocturnal hemoglobinuria	14
Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013–2022 in Finland	14
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab	14
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome	14
Clinical features and outcomes of 17 children with systemic juvenile xanthogranuloma (sJXG) including five complicated with hemophagocytic lymphohistiocytosis (HLH)	14
Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review	14
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia	13

Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics	13
Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes	13
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study	13
Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?	13
Correction to: Spanish registry of hemoglobinopathies and rare anemias (REHem- AR): demographics, complications, and management of patients with β-thalassemia	13
Successful rechallenge with azacytidine and venetoclax after sustained treatment-free remission in a relapsed acute myeloid leukemia patient: a case report	13
A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study)	13
Safety and efficacy of daratumumab in Chinese patients with relapsed or refractory multiple myeloma: a phase 1, dose-escalation study (MMY1003)	13
PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study	13
Critical risk factors analysis of infection-associated hemophagocytic lymphohistiocytosis in children	13
Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation	12
Prognostic factors and effect modifiers in patients with relapsed or refractory follicular lymphoma who failed at least two lines of therapy: a systematic literature and expert clinical review	12
TGFBI regulates the TGF-β pathway to affect the malignant progression and cisplatin sensitivity in diffuse large B-cell lymphoma	12
Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?	12
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM)	12
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report	12
Feasibility of allogeneic stem cell transplantation (HSCT) in patients with acute myeloid leukemia previously treated with CPX-351: report from a single center	12
Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia/small lymphocytic lymphoma: a systematic review and meta-analysis	12
Clinical significance of C-reactive protein/platelet ratio from diagnosis to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia	12
TRAF3IP3::FGFR1: a novel FGFR1 fusion identified in an aggressive case of acute myeloid leukemia	12
Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab	12
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial	12
Are accessory spleen screening and resection in refractory immune cytopenia an effective strategy or a waste of resources?	12
Platelet recovery with ibrutinib therapy in patient with treatment-refractory immune thrombocytopenia	12
Re-induction therapy in patients with acute myeloid leukemia not in complete remission after the first course of treatment	12
Optimal dosage of rituximab for children with Burkitt lymphoma	12
A cohort of allogeneic hematopoietic stem cell transplantation for pediatric rare diseases (allo-HSCT-PRD): design and preliminary results	12
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes	12
Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomes	12
Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia patient and its implications for clinical treatment	12
Interim PET in follicular lymphoma: more patience, please	12
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use	12
Pseudothrombocytopenia, beyond a laboratory phenomenon: study of 192 cases	11
Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients	11
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report	11
Analytical considerations affecting plasma free haemoglobin, the haemolysis index, and correlation with clinical outcomes in sickle cell disease	11
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy– a report of two cases	11
Validity of the criteria for clinical transformation of follicular lymphoma: analysis of a mostly biopsied cohort	11
Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective	11
Post-transplant transient abnormal myelopoiesis evolving from a GATA1 mutant clone in umbilical cord blood	11
The experience of diagnosis and treatment for TAFRO syndrome	11
Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia	11
In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation	11
Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study	11
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience	11
A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate	11
Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis	11
The roles of ubiquitination in AML	11
A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs	11
Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments	11
Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis	11
Overcoming right heart failure through successful treatment of cardiac dominant diffuse large B-cell lymphoma: a case report	11
Prognostic significance of early nk cell recovery in pediatric t-cell replete allogeneic hematopoietic stem cell transplantation	11
Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Cen	11
Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma	11
Challenges in accuracy in molecular genetic diagnosis of childhood AML: case series	11
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors	11
Romiplostim versus Recombinant human thrombopoietin in umbilical cord blood transplantation: a single-center retrospective study	10
Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency	10
Initial management of patients with acquired aplastic anemia in the United States: results from a large national claims database	10
Identification of a novel cryptic variant chromosomal rearrangement involving 9q34, 22q11.2, and 5q22 resulting in ins(9;22) and t(5;22) in chronic myeloid leukemia: a case report	10
A comparative study of platelet storage lesion in platelet-rich plasma under cryopreservation	10
Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms	10
An unexpected find of multifocal extranodal marginal zone lymphoma	10
Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience	10
Comparison of prognostication by IPSS-M, IPSS-R and AIPSS-MDS in the context of limited availability of molecular data in daily clinical practice	10
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation	10
Bibliometric analysis of worldwide research on Polycythemia Vera in the 21st century	10
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin’s lymphoma: A single-center prospective study	10
Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed	10
Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009–2020	10
Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia	10
Tandem autologous hematopoietic stem cell transplantation in multiple myeloma: A historical perspective and current challenges	10
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemia	10
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma	10
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study	10
Prognostic value of laboratory biomarkers for mortality risk stratification in thrombotic thrombocytopenic purpura	10
Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia	10
Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial	10
2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome	10

Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings	9
Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations	9
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL)	9
Case report:Clinical manifestations and therapeutic options following rhTPO-induced neutralizing antibody production in a child with immune thrombocytopenia	9
Association of inflammation and abnormal lipid metabolism with risk of thrombosis and thrombosis progression in patients with polycythemia vera: a retrospective study	9
N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study	9
Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide	9
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management	9
Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders	9
Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China	9
Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL	9
A predictive diagnostic model for refractory diffuse large B-cell lymphoma: a single-center retrospective cohort study	9
Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients	9
Clinical features and outcomes in large granular lymphocyte leukemia − associated pure red cell aplasia with STAT3 mutation	9
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population	9
Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine	9
Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma	9
miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia	9
Bone marrow involvement is a risk factor for infusion-related reactions in patients with follicular lymphoma treated by obinutuzumab	9
A synchronous therapy with daratumumab and enzymatic replacement therapy (ERT) in a patient with Gaucher disease and multiple myeloma	9
L-DEP regimen is effective as an initial therapy for adult EBV-HLH	9
Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma	9
Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia	9
Sickle cell disease and acute leukemia: one case report and an extensive review	9
Prognostic significance of angiogenesis-associated molecules and Immunologic characteristic in elderly patients with acute myeloid leukemia	9
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey	9
Magnitude of cumulative iron overload correlates with the severity of anemia in untreated non-transfusion-dependent β-thalassemia	9
Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia	9
Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry	9
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?	9
Impact of protein-energy malnutrition on outcomes of patients with sickle cell disease: an analysis of the National inpatient sample	9
Association between N-acetylcysteine treatment and in-hospital mortality in adult patients with acquired thrombotic thrombocytopenic purpura: a cohort study	8
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)	8
Benefit of consolidative radiation in patients with extranodal limited-stage diffuse large B-cell lymphoma: a multicenter retrospective study in China	8
Enasidenib as treatment for AML with IDH2 mutation: multicenter real-life study of the early-access program in Spain	8
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory	8
Successful treatment with oseltamivir phosphate in children with ITP who failed first-line therapy: a case series report	8
Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL	8
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients	8
Polatuzumab vedotin and bendamustine (Pola-B) was effective for refractory CD20-negative double-expressor lymphoma	8
A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors	8
Exploring the baseline cardiac function and its correlation with risk stratification in children diagnosed with acute lymphoblastic leukemia	8
Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based study	8
Safe and successful teclistamab treatment in very elderly multiple myeloma (MM) patients: a case report and experience from a total of three octogenarians	8
CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia	8
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study	8
Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives	8
Impact of antithymocyte globulin on blood cyclosporin A levels in aplastic anemia patients	8
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis	8
Broadening perspectives: redefining the role of obesity in ITP	8
MALAT1/miR-582-5p/GALNT1/MUC1 axis modulates progression of AML leukemia stem cells by regulating JAK2/STAT3 pathway	8
Prognostic factors in patients with secondary hemophagocytic lymphohistioc ytosis in a Chinese cohort	8
Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia	8
A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1	8
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma	8
Single-agent brentuximab vedotin as frontline therapy for Hodgkin lymphoma patients with severe hepatic impairment: a report of two cases	8
The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)	8
Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmunization in transfusion-dependent patients with thalassemia: the first case-control study in Iran	8
Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabru	8
Efficacy and safety analysis of China’s first 10% IVIg (RonsenGlob) therapy in treating adult ITP	8
Clinical features and fusion gene analysis of two Torque Teno Mini virus associated acute promyelocytic leukemia cases	8
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group	8
Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi- associated genes	8
Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study	8
Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA	8
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study	8
A case of visual impairment due to HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation in childhood acute myeloid leukemia-M2 subtype	8
Speckle tracking echocardiography and β-thalassemia major. A systematic review	8
How to combine multiple tools for the genetic diagnosis work-up of pediatric B-cell acute lymphoblastic leukemia	8
Recent advances in CD5+ diffuse large B-cell lymphoma	8
Enhancing outcomes of childhood acute lymphoblastic leukemia in workplace diversity in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group	8
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma	8
T(11;14) with multiple myeloma: Standard risk survival but slow and poor response	8
CALR loss-of-heterozygosity as a potential driver for extramedullary AML	8
Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation	8
Internal tandem duplications of FLT3 containing exogenous sequences are associated with poor clinical outcomes in acute myeloid leukemia	8
Real-world data of siltuximab for Chinese patients with iMCD: combination with BCD regimen as a potential approach for severe cases	8
A case report of dyskeratosis congenita caused by a novel TERC mutation	8
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement	8
Alectinib maintenance therapy following cord blood transplantation for relapsed pediatric anaplastic large cell lymphoma with central nervous system involvement	8
Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia	8
Recurrent PAX5::ZCCHC7 rearrangement in B-cell acute lymphoblastic leukemia	8
Mutations of epigenetic modifier genes predict poor outcome in adult acute lymphoblastic leukemia	7
Comment on: Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis	7
Ruxolitinib for pediatric acute and chronic graft-versus-host disease: a single-center retrospective study of efficacy and safety	7
Comparison of total body irradiation (TBI) and Non-TBI conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with peripheral T cell lymphoma: a multicenter retrospec	7
Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab – case report and review of the literature	7
The life threat in hematopoietic allogeneic stem cell transplantation - an interview and focus group study on health care professionals’ perspectives	7
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzum	7
Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection	7
Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study	7
Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients	7
A study of the relationship between circulating cytokines (interleukin-2 receptor and tumor necrosis factor receptor 2) and risk of B-cell non-hodgkin lymphoma	7
Loeys-Dietz syndrome with concomitant aplastic anemia	7
USF2 promotes autophagy and proliferation in chronic lymphocytic leukemia by inhibiting STUB1-induced NFAT5 ubiquitination	7